Nontuberculous mycobacteria in diffuse panbronchiolitis

被引:13
作者
Tsuji, Takahiro [1 ]
Tanaka, Eisaku [1 ]
Yasuda, Ikkoh [1 ]
Nakatsuka, Yoshinari [1 ]
Kaji, Yusuke [1 ]
Yasuda, Takehiro [1 ]
Hashimoto, Seishu [1 ]
Hwang, Moon Hee [1 ]
Hajiro, Takashi [1 ]
Taguchi, Yoshio [1 ]
机构
[1] Tenri Hosp, Dept Resp Med, Tenri, Nara 6328552, Japan
关键词
bronchiectasis; Japan; mucociliary clearance; prevalence; CYSTIC-FIBROSIS PATIENTS; AVIUM-INTRACELLULARE COMPLEX; LUNG-DISEASE; PULMONARY-DISEASE; BRONCHIECTASIS; CLARITHROMYCIN; INFECTIONS; EPIDEMIOLOGY; PREVALENCE; CLEARANCE;
D O I
10.1111/resp.12412
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objectiveNontuberculous mycobacterial (NTM) lung disease secondary to cystic fibrosis (CF) has been reported, but there is limited data about NTM prevalence in non-CF bronchiectasis. We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), a disorder also characterized by reduced mucociliary clearance with bronchiectasis. MethodsWe reviewed mycobacterial cultures, patient characteristics and computed tomography findings of 33 patients with DPB between January 2000 and December 2012. Prevalence was based on at least one positive NTM culture. ResultsMean patient age was 51.5 years. During a mean 162.8-month follow-up, the prevalence of NTM in sputum was 21.2% (seven patients). Of the seven positive patients, six had Mycobacterium avium complex, one had M.kansasii and M.chelonae co-cultured with M.avium complex. Three patients were positive twice, and two had positive smears. The mean time from DPB diagnosis to the first positive result was 194.6 months. NTM-positive patients tended to have lower forced expiratory volume in 1s (% predicted) than NTM-negative patients (50.0% vs 77.3%, P=0.03), but there were no radiological or clinical differences between the two groups. ConclusionsOur observations suggest that NTM is found more often in DPB. Defects of mucociliary clearance may predispose individuals to NTM infection. Defects in the mucociliary transport system are assumed to be a predisposing factor to nontuberculous mycobacterial (NTM) infection. We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), which is characterized by mucociliary dysfunction. We detected a high prevalence comparable to rates in cystic fibrosis.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 33 条
[1]   NONTUBERCULOUS MYCOBACTERIAL DISEASE IN ADULT CYSTIC-FIBROSIS PATIENTS [J].
AITKEN, ML ;
BURKE, W ;
MCDONALD, G ;
WALLIS, C ;
RAMSEY, B ;
NOLAN, C .
CHEST, 1993, 103 (04) :1096-1099
[2]   DELTA-F508 MUTATION OF CYSTIC-FIBROSIS GENE IS NOT FOUND IN CHRONIC-BRONCHITIS WITH SEVERE OBSTRUCTION IN JAPAN [J].
AKAI, S ;
OKAYAMA, H ;
SHIMURA, S ;
TANNO, Y ;
SASAKI, H ;
TAKISHIMA, T .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (03) :781-783
[3]   Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease [J].
Aksamit, TR .
CLINICS IN CHEST MEDICINE, 2002, 23 (03) :643-+
[4]   Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis [J].
Binder, Alison M. ;
Adjemian, Jennifer ;
Olivier, Kenneth N. ;
Prevots, D. Rebecca .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (07) :807-812
[5]   MYCOBACTERIA AS A CAUSE OF INFECTIVE EXACERBATION IN BRONCHIECTASIS [J].
CHAN, CHS ;
HO, AKC ;
CHAN, RCY ;
CHEUNG, H ;
CHENG, AFB .
POSTGRADUATE MEDICAL JOURNAL, 1992, 68 (805) :896-899
[6]   CLARITHROMYCIN AND OTHER ANTIMICROBIAL AGENTS IN THE TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM INFECTIONS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
DAUTZENBERG, B ;
SAINTMARC, T ;
MEYOHAS, MC ;
ELIASZEWITCH, M ;
HANIEZ, F ;
ROGUES, AM ;
DEWIT, S ;
COTTE, L ;
CHAUVIN, JP ;
GROSSET, J .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (03) :368-372
[7]   Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics [J].
Fowler, S. J. ;
French, J. ;
Screaton, N. J. ;
Foweraker, J. ;
Condliffe, A. ;
Haworth, C. S. ;
Exley, A. R. ;
Bilton, D. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) :1204-1210
[8]  
Grenier P, 1993, J Thorac Imaging, V8, P213, DOI 10.1097/00005382-199322000-00006
[9]   An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [J].
Griffith, David E. ;
Aksamit, Timothy ;
Brown-Elliott, Barbara A. ;
Catanzaro, Antonino ;
Daley, Charles ;
Gordin, Fred ;
Holland, Steven M. ;
Horsburgh, Robert ;
Huitt, Gwen ;
Iademarco, Michael F. ;
Iseman, Michael ;
Olivier, Kenneth ;
Ruoss, Stephen ;
von Reyn, C. Fordham ;
Wallace, Richard J., Jr. ;
Winthrop, Kevin .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) :367-416
[10]  
IMAI T, 1995, J NUCL MED, V36, P1355